WHC is still in active development. Read this to understand our approach.
depiction of RQEUFEKYXDPUSK-UHFFFAOYSA-N.svg
isomerdesign

1-PEA

Check on isomerdesign

pubchem

1-Phenylethylamine

Check on pubchem

wiki

1-Phenylethylamine

Check on wiki

Data

InChI: InChI=1S/C8H11N/c1-7(9)8-5-3-2-4-6-8/h2-7H,9H2,1H3

Synonyms: a-phenylethylamine,(+)-1-phenylethylamine,BENZYLAMINE, .ALPHA.-METHYL-, DL-,racemic alpha-methyl-benzenemethanamine,alpha-Phenylethylamine,1-Phenyl-ethylamine,(+/-)-.ALPHA.-PHENYLETHYLAMINE,SCHEMBL4701869,(+/-)- alpha -Methylbenzylamine,1(r,s)-phenylethylamine,(+/-)-.ALPHA.-PHENETHYLAMINE,Benzenemethanamine, .alpha.-methyl-, (.+/-.)-,Benzenemethanamine, .alpha.-methyl-,alpha-Methylbenzylamine, 99%,AKOS016039387,EN300-17925,D77753,alpha-methylbenzyl amine,Benzene, (1-amino-ethyl)-,DL-1-phenethylamine,(S)-.alpha.-Methylbenzenemethanamine,MFCD00008069,(R)-.alpha.-Methylbenzenemethanamine,N-FMOC-AMINO-4-KETOCYCLOHEXYLCARBOXYLICACID,SCHEMBL830,(+) alpha-methylbenzylamine,F0798-0597,L-(-)-.alpha.-Phenylethylamine,EINECS 210-545-8,(+/-)-alpha-Methylbenzylamine,Benzenemethanamine, .alpha.-methyl-, (R)-,1-phenylethyl amine,CHEBI:670,WLN: 1M1R,(^+)-1-Phenylethylamine, 98+%,alpha-methyl benzylamine,(+)1-phenylethan-1-amine,1-Phenylethylamine,rac-1-phenylethanamine,Benzylamine, alpha-methyl-,Ethanamine, 1-phenyl-,APHEA,DB-015888,(+/-)-1-Phenyl-ethylamine,C02455,Benzenemethanamine, alpha-methyl-,UNII-HZ9DM6B2MT,1-phenyl-ethyl-amine,Benzenemethaneamine, .alpha.-methyl-,1-Phenyl-1-ethanamine,alpha-Phenethylamine,alpha-Methylbenzenemethanamine,HZ9DM6B2MT,Q3560549,618-36-0,DL-alpha-Methylbenzylamine,HSDB 2742,(-)-1-phenylethylamine,(R)-(+)-alfa-Methylbenzylamine,1-Phenylethanamine,racemic 1-phenylethylamine,BDBM50023171,alpha-methyl benzyl amine,(+/-)-1-(phenyl)ethylamine,ALBB-032928,(S)-alpha-methyl benzylamine,PS-4601,CS-W013564,Ethylamine, 1-phenyl-,(RS)-alpha-methylbenzylamine,FT-0601072,1-Phenethylamine,1-Fenylethylamin,Benzenemethaneamine, alpha-methyl-,α-Me-benzylamine,1-PEA,l-phenylethylamine,NSC-8391,EINECS 202-706-6,alpha-methyl-benzylamine,Sumine 2079,(-)alpha-phenylethylamine,(-) alpha-methyl-benzylamine,(rs)-1-phenylethylamine,(S)-(-)-.alpha.-Methylbenzylamine,a-phenethylamine,AI3-03116,(1-phenylethyl)amine,a-methylbenzenemethanamine,(1-Aminoethyl)benzene,Benzenemethanamine, .alpha.-methyl-, (S)-,DB-054000,Z57102377,98-84-0,DL-.ALPHA.-METHYLBENZYLAMINE,STK397443,Benzylamine, .alpha.-methyl-, (.+/-.)-,.ALPHA.-METHYLBENZENEMETHANAMINE,(-)-alpha-phenylethylamine,BCP32849,AKOS000119070,EC 210-545-8,(-) alpha methyl benzyl amine,NSC8391,DL-1-Phenylethylamine,1-Phenyl ethylamine,(+/-)-1-phenylethanamine,(+)-alpha-methyl-benzylamine,alpha-methylbezylamine,.ALPHA.-AMINOETHYLBENZENE,DL-|A-Methylbenzylamine DL-|A-Phenylethylamine,a-methylbenzylamine,(+/-)-1-phenyl-ethanamine,alpha-Aminoethylbenzene,(-)-alpha-methylbenzylamine,(-)-alpha-methylbenzenemethanamine,Benzenemethanamine, a-methyl-,phenylethan-1-amine,(-)-.alpha.-Phenethylamine,1-Phenylethan-1-amine,1-Phenylethanamine #,.alpha.-Phenethylamine,Benzylamine, .alpha.-methyl-,dl-1-phenylethyl amine,.alpha.-Phenylethylamine,FT-0604486,a-aminoethylbenzene,W-105090,(R,S)-.ALPHA. METHYLBENZYLAMINE,1-PHENETHYLAMINE [HSDB],racemic 1-phenylethanamine,(RS)-.ALPHA.-METHYLBENZYLAMINE,(+)-alpha-methylbenzylamine,AS-80972,AM20060838,(S)-(-)-a-methyl-benzylamine,(S)-1-phenylethanamine;(1S)-1-phenylethanamine,CHEMBL278059,racemic alpha-methylbenzylamine,1-Fenylethylamin [Czech],L(-)-.alpha.-Methylbenzylamine,(+/-)-1-Phenylethylamine,FT-0658781,1-phenylethan-1-amine,(-)-alpha-methyl-benzylamine,1-Amino-1-phenylethane,NSC 8391,ALPHA-METHYLBENZYLAMINE,.ALPHA.-METHYLBENZYLAMINE [MI],DTXSID40862301,α-PEA,Timepidiumbromide,M0165,.alpha.-Methylbenzylamine,(+)-alpha-methyl benzyl amine,alpha-Methylbenzylamine

Estimated data

Solubility: -0.364 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 65.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.